Retension Pharmaceuticals
RTSN
#9741
Rank
$0.10 B
Marketcap
$12.39
Share price
12.23%
Change (1 day)
N/A
Change (1 year)

Retension Pharmaceuticals (RTSN) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : $31.04 Million USD

According to Retension Pharmaceuticals's latest financial reports the company's total liabilities are $31.04 Million USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Retension Pharmaceuticals - Total liabilities on balance sheet (from 2025 to 2026)